科兴制药公告，股东科益医药计划通过询价转让方式转让603.77万股公司股份，占公司总股本的3.00%。本次转让价格下限不低于发送认购邀请书之日(含当日)前20个交易日公司股票交易均价的70%。受让方为具备相应定价能力和风险承受能力的机构投资者。此次转让旨在满足科益医药自身资金需求，不通过集中竞价交易方式或大宗交易方式进行，不属于通过二级市场减持。转让后6个月内不得转让。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.